France · Delayed Price · Currency is EUR Robertet Earnings Call Transcripts
Fiscal Year 2026
-
Organic growth reached 2.8% in H1 2026, led by strong fragrance and health & beauty performance, while raw materials and flavors declined due to tough comparatives. EBITDA margin remained robust at 21.1%, with continued investment and a positive outlook for full-year growth and profitability.
Fiscal Year 2025
-
Strong organic growth and margin expansion in 2025, with EBITDA margin up to 20.6% and net income rising 14.8%. Facing headwinds from FX, raw material, and transport costs, but maintaining disciplined investment and M&A strategy. Guidance for 2026 is cautious, targeting 5% revenue growth.
-
Solid H1 2025 results with 9.2% organic growth, margin improvements, and strong performance in raw materials and flavors. U.S. tariffs and currency volatility pose headwinds for H2, but price increases and ongoing M&A are expected to support long-term growth.
Fiscal Year 2024
-
Double-digit growth in 2024 was driven by all divisions and regions, with EBITDA margin rising to 19.4% and net income up to €90 million. Expansion in Asia and the Americas, targeted acquisitions, and strong cash flow supported increased CapEx and a higher dividend. Regulatory, tariff, and raw material risks remain key challenges.
-
Strong H1 2024 results with 10.1% sales growth and 21.4% EBITDA margin, driven by restocking, favorable raw material costs, and successful integration of Sonarome. Full-year organic growth is targeted at 7%, with margin improvement expected despite H2 cost pressures.